scispace - formally typeset
Y

Yann Abraham

Researcher at Janssen Pharmaceutica

Publications -  18
Citations -  2384

Yann Abraham is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Population & Hippo signaling pathway. The author has an hindex of 10, co-authored 17 publications receiving 2107 citations. Previous affiliations of Yann Abraham include Curie Institute & Novartis.

Papers
More filters
Journal ArticleDOI

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

TL;DR: Quantitative profiling of the drugs Imatinib, dasatinib and bosutinib in K562 cells confirms known targets including ABL and SRC family kinases and identifies the receptor tyrosine kinase DDR1 and the oxidoreductase NQO2 as novel targets of imatinib.
Journal ArticleDOI

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

TL;DR: This work revealed the selectivity with which 16 HDAC inhibitors target multiple HDAC complexes scaffolded by ELM-SANT domain subunits, including a novel mitotic deacetylase complex (MiDAC) and identified several non-HDAC targets for hydroxamate inhibitors.
Journal ArticleDOI

A Role for Centrin 3 in Centrosome Reproduction

TL;DR: The results demonstrate that, in spite of the large differences in centrosome structure among widely divergent species, the Centrosome pathway of reproduction is conserved.